Results 161 to 170 of about 3,812 (201)
Drug-Induced Sclerosing Cholangitis Leading to Discontinuation of Treatment in a Patient with Metastatic Breast Cancer: A Case Report. [PDF]
Aso S +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
IgG4-Related Sclerosing Cholangitis
Current Hepatology Reports, 2020IgG4-related sclerosing cholangitis (ISC) is a frequent occurrence. However, its diagnosis is difficult. This review summarizes the clinical features, pathogenesis, differential diagnosis, and management of ISC. A precise diagnosis of ISC is important. Diagnosis is based on the Japanese criteria which has recently been provided.
Akash Singh, Virendra Singh
openaire +1 more source
IgG4-related sclerosing cholangitis— A great mimicker
Indian Journal of Gastroenterology, 2020IgG4-related disease (IgG4 RD) is a multisystem disorder characterized by tumefactive (mass forming) lesions, storiform fibrosis, and IgG4-positive plasma cell infiltration. IgG4 sclerosing cholangitis (IgG4 SC) is the biliary manifestation of IgG4 RD, often in association with autoimmune pancreatitis (AIP).
Hemanta Kumar Nayak +5 more
openaire +2 more sources
IgG4-Related Sclerosing Cholangitis Mimicking Cholangiocarcinoma
Zeitschrift für Gastroenterologie, 2012IgG4-related disease has gained increased attention worldwide. While the initial focus was on autoimmune pancreatitis which was first described in Asian populations and turned out to be of relevance in Western populations too, the scope has recently broadened towards a notion of a multi-systemic disease with very diverse manifestations such as ...
M, Nguyen-tat +9 more
openaire +2 more sources
Diagnostic procedures for IgG4-related sclerosing cholangitis
Journal of Hepato-Biliary-Pancreatic Sciences, 2010IgG4-related sclerosing cholangitis (IgG4-SC) is one of several diseases associated with autoimmune pancreatitis (AIP). However, diffuse cholangraphic abnormalities seen in association with AIP may resemble those seen in primary sclerosing cholangitis (PSC), and the presence of segmental stenosis suggests cholangiocarcinoma.
Takahiro, Nakazawa +5 more
openaire +2 more sources
Cholangioscopic view of IgG4‐related sclerosing cholangitis
Journal of Hepato-Biliary-Pancreatic Sciences, 2010AbstractWe present here possible characteristic POCS findings of IgG4‐SC, which include proliferation of dilated and tortuous vessels, and relatively smooth and somewhat edematous mucosa without easy oozing.
Ichiro, Yasuda +2 more
openaire +2 more sources
Autoimmune pancreatitis and IgG4-related sclerosing cholangitis
Current Opinion in Rheumatology, 2011Autoimmune pancreatitis (AIP) is a peculiar type of pancreatitis with a presumed autoimmune etiology. AIP is frequently associated with stenosis of the bile duct in the form of IgG4-related sclerosing cholangitis. This article reviews recent advances in clinicopathological findings for AIP and IgG4-related sclerosing cholangitis.AIP is currently ...
Kensuke, Takuma +2 more
openaire +2 more sources
2021
Cholangiocarcinoma is a lethal cancer of the bile ducts with median survival of only 5–12 months after diagnosis. Surgical resection and liver transplantation are the only available curative options. Many patients with cholangiocarcinoma are not eligible for these therapies due to advanced stage of cholangiocarcinoma at the time of diagnosis.
Ahmad Hassan Ali, Elizabeth J. Carey
openaire +1 more source
Cholangiocarcinoma is a lethal cancer of the bile ducts with median survival of only 5–12 months after diagnosis. Surgical resection and liver transplantation are the only available curative options. Many patients with cholangiocarcinoma are not eligible for these therapies due to advanced stage of cholangiocarcinoma at the time of diagnosis.
Ahmad Hassan Ali, Elizabeth J. Carey
openaire +1 more source
IgG4-Related Sclerosing Cholangitis in Europe
2018IgG4-related sclerosing cholangitis (IgG4-RC) is a clinical condition described in the last 10 years, according to the growing knowledge on IgG4-related diseases (IgG4-RD). In Europe, few studies have been published on IgG4-RC and the information available are mainly derived from patients suffering from autoimmune pancreatitis (AIP). The chapter report
de Pretis, Nicolò +3 more
openaire +1 more source

